SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-124190
Filing Date
2020-04-29
Accepted
2020-04-29 06:12:34
Documents
3
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d852589ddefa14a.htm DEFA14A 18514
2 GRAPHIC g852589naa1.jpg GRAPHIC 185064
3 GRAPHIC g852589naa2.jpg GRAPHIC 134058
  Complete submission text file 0001193125-20-124190.txt   459165
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35670 | Film No.: 20827174
SIC: 2834 Pharmaceutical Preparations